72F fusion protein vaccine

From Wikipedia, the free encyclopedia
  (Redirected from 72F fusion protein)
Jump to: navigation, search

72F fusion protein vaccine is a candidate tuberculosis vaccine created by Statens Serum Institut (SSI). The 72F fusion protein is composed of the Rv0125 and Rv1196 proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.

See also[edit]

References[edit]